Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll New molecular classifications of breast cancer Cianfrocca M; Gradishar WCA Cancer J Clin 2009[Sep]; 59 (5): 303-13Traditionally, pathologic determinations of tumor size, lymph node status, endocrine receptor status, and human epidermal growth factor receptor 2 (HER2) status have driven prognostic predictions and adjuvant therapy recommendations for patients with early stage breast cancer. However, these prognostic and predictive factors are relatively crude measures, resulting in many patients being overtreated or undertreated. As a result of gene expression assays, there is growing recognition that breast cancer is a molecularly heterogeneous disease. Evidence from gene expression microarrays suggests the presence of multiple molecular subtypes of breast cancer. The recent commercial availability of gene expression profiling techniques that predict risk of disease recurrence as well as potential chemotherapy benefit have shown promise in refining clinical decision making. These techniques will be reviewed in this article.|*Molecular Diagnostic Techniques/economics[MESH]|Breast Neoplasms/*classification/diagnosis/genetics/pathology[MESH]|Cost-Benefit Analysis[MESH]|Female[MESH]|Gene Expression Profiling[MESH]|Gene Expression Regulation, Neoplastic[MESH]|Humans[MESH]|Oligonucleotide Array Sequence Analysis/economics[MESH]|Prognosis[MESH]|Reverse Transcriptase Polymerase Chain Reaction[MESH] |